Citation: Hp. Kapfhammer et H. Hippius, SPECIAL FEATURE - PHARMACOTHERAPY IN PERSONALITY-DISORDERS, Journal of personality disorders, 12(3), 1998, pp. 277-288
Citation: K. Heinrich et al., 30 YEARS PHARMACOPSYCHIATRY - THE JOURNAL AND ITS EDITOR-IN-CHIEF MULLEROERLINGHAUSEN,BRUNO, Pharmacopsychiatry, 31(1), 1998, pp. 1-2
Authors:
TEIPEL SJ
HAMPEL H
ALEXANDER GE
SCHAPIRO MB
HORWITZ B
TEICHBERG D
DALEY E
HIPPIUS H
MOLLER HJ
RAPOPORT SI
Citation: Sj. Teipel et al., DISSOCIATION BETWEEN CORPUS-CALLOSUM ATROPHY AND WHITE-MATTER PATHOLOGY IN ALZHEIMERS-DISEASE, Neurology, 51(5), 1998, pp. 1381-1385
Authors:
SASS H
SOYKA M
MANN K
ZIEGLGANSBERGER W
HIPPIUS H
DIETERLE D
DILLING H
WETTERLING T
JOHN U
KANITZ RD
VELTRUP C
BUSCHER M
RICHARTZ E
OVERBERG B
SEGERATH KD
HASEKE J
LANDEFELD H
GROSS J
KRAUSS N
NIEDERMEYER U
VONKEYSERLINGK HG
KRETSCHMAR C
GIENKE E
HAAS S
BIALONSKI HG
TOELLE R
POEHLKE T
OSKENT A
ZIEGLER B
TRABERT W
WEISE R
KROH T
KIELSTEIN V
BONING J
Citation: H. Sass et al., RELAPSE PREVENTION BY ACAMPROSATE - RESULTS FROM A PLACEBO-CONTROLLEDSTUDY ON ALCOHOL DEPENDENCE, Archives of general psychiatry, 53(8), 1996, pp. 673-680
Citation: Hy. Meltzer et H. Hippius, THE ASSESSMENT AND MANAGEMENT OF TREATMENT-RESISTANT SCHIZOPHRENIA INPERSPECTIVE, European psychiatry, 10, 1995, pp. 3-5
Authors:
ANGST J
BORBELY A
ENGEL RR
FERNER U
GASZNER P
HIPPIUS H
LADER M
LINGJAERDE O
RUTHER E
RZWUSKA M
SALETU B
SEDVALL G
SOLDATOS C
STEFANIS CN
STOLL KD
Citation: J. Angst et al., REPORT ON THE 6TH CONSENSUS CONFERENCE ON THE METHODOLOGY OF CLINICAL-TRIALS WITH HYPNOTIC DRUGS, Pharmacopsychiatry, 28(1), 1995, pp. 2-7
Authors:
CASSANO GB
TONI C
PETRACCA A
DELTITO J
BENKERT O
CURTIS G
HIPPIUS H
MAIER W
SHERA D
KLERMAN G
Citation: Gb. Cassano et al., ADVERSE-EFFECTS ASSOCIATED WITH THE SHORT-TERM TREATMENT OF PANIC DISORDER WITH IMIPRAMINE, ALPRAZOLAM OR PLACEBO, European neuropsychopharmacology, 4(1), 1994, pp. 47-53
Authors:
VARTANIAN ME
PANTELEYEVA GP
GORKOV VA
NIKIFOROVA IY
RAYUSHKIN VA
ROZOVA GI
HIPPIUS H
Citation: Me. Vartanian et al., THE ROLE OF HEREDITY, CLINICAL AND PHARMA COKINETIC FACTORS IN THE PREDICTION OF LITHIUM-SALTS PROPHYLACTIC EFFECT, Zurnal nevropatologii i psihiatrii im. S.S. Korsakova, 94(6), 1994, pp. 52-58
Citation: M. Soyka et al., EXACERBATION OF AFFECTIVE PSYCHOSIS AFTER LENGTHY TREATMENT WITH BENZODIAZEPINES - WHAT IS THE MOST EFFECTIVE APPROACH TO TREATMENT, Nervenarzt, 65(9), 1994, pp. 628-632
Citation: U. Klages et al., ATYPICAL NEUROLEPTICS, PHARMACOLOGY AND C LINICAL RELEVANCE, Fortschritte der Neurologie, Psychiatrie, 61(11), 1993, pp. 390-398
Authors:
GUNTHER W
BAGHAI T
NABER D
SPATZ R
HIPPIUS H
Citation: W. Gunther et al., EEG ALTERATIONS AND SEIZURES DURING TREATMENT WITH CLOZAPINE - A RETROSPECTIVE STUDY OF 283 PATIENTS, Pharmacopsychiatry, 26(3), 1993, pp. 69-74
Authors:
GROHMANN R
STROBEL C
RUTHER E
DIRSCHEDL P
HELMCHEN H
HIPPIUS H
MULLEROERLINGHAUSEN B
SCHMIDT LG
WOLF B
Citation: R. Grohmann et al., ADVERSE PSYCHIC REACTIONS TO PSYCHOTROPIC-DRUGS - A REPORT FROM THE AMUP STUDY, Pharmacopsychiatry, 26(3), 1993, pp. 84-93